Background: Retinopathy of prematurity (ROP) is a sight-threatening disease affecting extremely preterm infants. The introduction of new ROP screening surveillance systems, with higher sensitivity and specificity than established ROP screening guidelines, has the potential to reduce the number of stressful eye examinations in these infants. Objectives: To improve the specificity of the WINROP (Weight, Insulin-like growth factor-I, Neonatal, ROP) surveillance system, identifying extremely preterm infants requiring treatment for ROP. Methods: Two cohorts that had previously been subjected to WINROP analyses were included and reevaluated in this study. The weight at WINROP alarm for extremely preterm infants, born at gestational age <27 weeks, was reevaluated and by establishing ‘safe' WINROP alarm weight limits, an intersample reassessment of WINROP alarm was performed. The two cohorts were as follows: (1) the Extremely Preterm Infants in Sweden Study (EXPRESS) cohort, infants born in Sweden during 2004-2007 (n = 407), and (2) extremely preterm infants in a North American cohort, born during 2006-2009 (n = 566). Results: In the EXPRESS cohort, 12.5% (40/319) of the infants who previously received a WINROP alarm were now reassessed as having no alarm; the specificity of WINROP in EXPRESS increased from 23.9% (86/360) to 35.0% (126/360). In the North American cohort, 15.4% (81/526) were reassessed as having no alarm; the specificity increased from 8.5% (38/447) to 26.6% (119/447). The sensitivity persisted as 97.5% in EXPRESS (45/47) and 98.3% (117/119) in the North American cohort. Conclusions: The specificity of the WINROP surveillance system for extremely preterm infants can be significantly improved by reassessment using the weight at WINROP alarm.

1.
Austeng D, Kallen KB, Ewald UW, Jakobsson PG, Holmstrom GE: Incidence of retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden. Arch Ophthalmol 2009;127:1315-1319.
2.
Darlow BA, Horwood LJ, Clemett RS: Retinopathy of prematurity: risk factors in a prospective population-based study. Paediatr Perinat Epidemiol 1992;6:62-80.
3.
Lundgren P, Kistner A, Andersson EM, Hansen Pupp I, Holmstrom G, Ley D, Niklasson A, Smith LE, Wu C, Hellström A, Lofqvist C: Low birth weight is a risk factor for severe retinopathy of prematurity depending on gestational age. PLoS One 2014;9:e109460.
4.
Austeng D, Kallen KBM, Ewald UW, Wallin A, Holmstrom GE: Treatment for retinopathy of prematurity in infants born before 27 weeks of gestation in Sweden. Br J Ophthalmol 2010;94:1136-1139.
5.
Austeng D, Kallen KBM, Hellström A, Jakobsson PG, Johansson K, Tornqvist K, Wallin A, Holmstrom GE: Screening for retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden. Arch Ophthalmol 2011;129:167-172.
6.
Belda S, Pallas CR, De la Cruz J, Tejada P: Screening for retinopathy of prematurity: is it painful? Biol Neonate 2004;86:195-200.
7.
Hellström A, Perruzzi C, Ju M, Engstrom E, Hard AL, Liu JL, Albertsson-Wikland K, Carlsson B, Niklasson A, Sjodell L, LeRoith D, Senger DR, Smith LE: Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 2001;98:5804-5808.
8.
Hellström A, Engstrom E, Hard AL, Albertsson-Wikland K, Carlsson B, Niklasson A, Lofqvist C, Svensson E, Holm S, Ewald U, Holmstrom G, Smith LE: Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 2003;112:1016-1020.
9.
Lofqvist C, Andersson E, Sigurdsson J, Engstrom E, Hard AL, Niklasson A, Smith LE, Hellström A: Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol 2006;124:1711-1718.
10.
Loqvist C, Hansen-Pupp I, Andersson E, Holm K, Smith LE, Ley D, Hellström A: Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulin-like growth factor I. Arch Ophthalmol 2009;127:622-627.
11.
Hellström A, Hard AL, Engstrom E, Niklasson A, Andersson E, Smith L, Lofqvist C: Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics 2009;123:E638-E645.
12.
Eriksson L, Liden U, Lofqvist C, Hellström A: WINROP can modify ROP screening praxis: a validation of WINROP in populations in Sormland and Vastmanland. Br J Ophthalmol 2014;98:964-966.
13.
Zepeda-Romero LC, Hard AL, Gomez-Ruiz LM, Gutierrez-Padilla JA, Angulo-Castellanos E, Barrera-de-Leon J, Ramirez-Valdivia JM, Gonzalez-Bernal C, Valtierra-Santiago CI, Garnica-Garcia E, Lofqvist C, Hellström A: Prediction of retinopathy of prematurity using the screening algorithm WINROP in a Mexican population of preterm infants. Arch Ophthalmol 2012;130:720-723.
14.
Wu C, Lofqvist C, Smith LE, VanderVeen DK, Hellström A, WINROP Consortium: Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity. Arch Ophthalmol 2012;130:992-999.
15.
Wu C, VanderVeen DK, Hellström A, Lofqvist C, Smith LE: Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity. Arch Ophthalmol 2010;128:443-447.
16.
Piyasena C, Dhaliwal C, Russell H, Hellström A, Lofqvist C, Stenson BJ, Fleck BW: Prediction of severe retinopathy of prematurity using the WINROP algorithm in a birth cohort in south east Scotland. Arch Dis Child Fetal Neonatal Ed 2014;99:F29-F33.
17.
Lundgren P, Stoltz Sjostrom E, Domellof M, Kallen K, Holmstrom G, Hard AL, Smith LE, Lofqvist C, Hellström A: WINROP identifies severe retinopathy of prematurity at an early stage in a nation-based cohort of extremely preterm infants. PLoS One 2013;8:e73256.
18.
Sun H, Kang W, Cheng X, Chen C, Xiong H, Guo J, Zhou C, Zhang Y, Hellström A, Lofqvist C, Zhu C: The use of the WINROP screening algorithm for the prediction of retinopathy of prematurity in a Chinese population. Neonatology 2013;104:127-132.
19.
Stevens B, Johnston C, Petryshen P, Taddio A: Premature infant pain profile: development and initial validation. Clin J Pain 1996;12:13-22.
20.
Stahl A, Hellström A, Smith LE: Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come? Neonatology 2014;106:254-260.
21.
Raghuveer TS, Bloom BT: A paradigm shift in the prevention of retinopathy of prematurity. Neonatology 2011;100:116-129.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.